Best Treatment for Gout
For acute gout flares, low-dose colchicine (1.2 mg followed by 0.6 mg one hour later), NSAIDs, or oral corticosteroids are strongly recommended as first-line treatments, with selection based on patient comorbidities. 1, 2
Treatment Algorithm for Gout
Acute Gout Flare Management
First-line options (start within 24 hours of symptom onset):
Patient-specific considerations:
Adjunctive therapy:
Long-term Management
Urate-lowering therapy (ULT) for patients with:
- Recurrent gout attacks (≥2 per year)
- Tophi
- Joint damage
- Urolithiasis
- Chronic kidney disease 2
First-line ULT:
Alternative ULT options:
Prophylaxis during ULT initiation:
Lifestyle modifications:
- Limit alcohol intake (especially beer)
- Reduce purine-rich food consumption (organ meats, shellfish)
- Avoid sugar-sweetened beverages and high-fructose foods
- Weight loss if obese
- Regular exercise
- Adequate fluid intake (at least 2 liters daily) 2
Evidence Quality and Considerations
The evidence for acute gout treatment is robust. Low-dose colchicine has been shown to be as effective as high-dose colchicine with significantly fewer side effects (23% vs. 77% reporting diarrhea) 1. The number needed to treat (NNT) for at least 50% pain relief with colchicine is 3, meaning one in three patients will experience significant pain relief 1.
NSAIDs have similar efficacy to colchicine, with one study showing tenoxicam having an NNT of 3 for achieving more than 50% pain relief 1. Multiple head-to-head comparisons have shown similar efficacy among different NSAIDs 1.
For long-term management, the American College of Rheumatology strongly recommends a treat-to-target approach with ULT to achieve serum urate levels <6 mg/dL 1. This approach has been shown to reduce flare frequency, decrease tophi, and improve quality of life 2.
Common Pitfalls to Avoid
Using high-dose colchicine regimens: Low-dose colchicine (1.8 mg total) is equally effective with fewer adverse effects compared to high-dose regimens 1, 3
Interrupting ULT during acute flares: Continue ULT during acute attacks 2
Inadequate prophylaxis when starting ULT: Always use prophylactic therapy when initiating ULT to prevent flares 2
Using fixed-dose allopurinol: Titrate to achieve target serum uric acid levels rather than using a fixed dose 2
Delayed treatment of acute flares: Initiate treatment within 24 hours of symptom onset for best results 2
Overlooking comorbidities: Consider cardiovascular and renal status when selecting therapy 2
By following this evidence-based approach to gout management, both acute symptoms and long-term complications can be effectively managed, improving patient outcomes and quality of life.